Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood

Abstract

Immunoglobulin (Ig)G antineutrophil cytoplasmic autoantibodies are causally associated with necrotizing vasculitides that are characterized immunopathologically by little or no deposition of immunoreactants, such as Wegener granulomatosis, microscopic polyangiitis, Churg–Strauss angiitis, "renal-limited" vasculitis and a number of drug-induced vasculitides. Clinical routine testing targets the antigens myeloperoxidase and proteinase 3. However, in all of the conditions mentioned, the renal histopathologic findings are indistinguishable. Churg–Strauss angiitis (characterized by necrotizing vasculitis, granulomatous inflammation and tissue eosinophilia), Wegener granulomatosis (characterized by necrotizing vasculitis and granulomatous inflammation) and microscopic polyangiitis (characterized by necrotizing vasculitis) often present with fever, weight loss and a multisystem involvement (ear, nose, throat, lung, eyes, peripheral nerve and heart). Fifty years ago these conditions were very often fatal within 6 months of diagnosis. The introduction of corticosteroids and cyclophosphamide has resulted in a dramatic clinical benefit. Patients who develop treatment-related morbidity can be switched from cyclophosphamide to azathioprine after achieving remission. In patients with less severe disease, methotrexate achieves remission with a success rate similar to that of cyclophosphamide. Plasma exchange, in association with immunosuppression, is likely to be a beneficial therapy for patients with severe kidney disease or pulmonary hemorrhage.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Brogan PA (2007) What's new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 22:1083–1094

    Article  Google Scholar 

  2. 2.

    Jennette JC, Falk RJ (2008) New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol 20:55–60

    CAS  Article  Google Scholar 

  3. 3.

    Pusey CD (2006) The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis. J Am Soc Nephrol 17:1221–1223

    Article  Google Scholar 

  4. 4.

    Kallenberg CG, Stegeman CA, Heeringa P (2008) Autoantibodies vex the vasculature. Nat Med 14:1018–1019

    CAS  Article  Google Scholar 

  5. 5.

    Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941

    CAS  Article  Google Scholar 

  6. 6.

    Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A (1999) International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111:507–513

    CAS  Article  Google Scholar 

  7. 7.

    Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, Jennette JC, McEvoy R, Pusey C, Pollock W, Trevisin M, Wiik A, Wong R, International Group for Consensus Statement on Testing, Reporting of Antineutrophil Cytoplasmic Antibodies (2003) Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 120:312–318

    CAS  Article  Google Scholar 

  8. 8.

    Moosig F, Lamprecht P, Gross WL (2008) Wegener's granulomatosis: the current view. Clin Rev Allergy Immunol 35:19–21

    CAS  Article  Google Scholar 

  9. 9.

    Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, Hoffman GS (1993) Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122:26–31

    CAS  Article  Google Scholar 

  10. 10.

    Laux-End R, Gerber HA, Sauvain MJ, Bianchetti MG (1997) Anti-neutrophil autoantibodies and systemic vasculitis: a report of five cases. Acta Paediatr 86:438–439

    CAS  Article  Google Scholar 

  11. 11.

    Stegmayr BG, Gothefors L, Malmer B, Müller Wiefel DE, Nilsson K, Sundelin B (2000) Wegener granulomatosis in children and young adults. A case study of ten patients. Pediatr Nephrol 14:208–213

    CAS  Article  Google Scholar 

  12. 12.

    Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED (2007) Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum 57:837–844

    CAS  Article  Google Scholar 

  13. 13.

    Belostotsky VM, Shah V, Dillon MJ (2002) Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 17:754–761

    Article  Google Scholar 

  14. 14.

    Jennette JC, Thomas DB, Falk RJ (2001) Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 18:3–13

    CAS  PubMed  Google Scholar 

  15. 15.

    Jayne D (2008) Challenges in the management of microscopic polyangiitis: past, present and future. Curr Opin Rheumatol 20:3–9

    Article  Google Scholar 

  16. 16.

    Besbas N, Ozen S, Saatci U, Topaloğlu R, Tinaztepe K, Bakkaloglu A (2000) Renal involvement in polyarteritis nodosa: evaluation of 26 Turkish children. Pediatr Nephrol 14:325–327

    CAS  Article  Google Scholar 

  17. 17.

    von Vigier RO, Trummler SA, Laux-End R, Sauvain MJ, Truttmann AC, Bianchetti MG (2000) Pulmonary renal syndrome in childhood: a report of twenty-one cases and a review of the literature. Pediatr Pulmonol 29:382–388

    Article  Google Scholar 

  18. 18.

    Langford CA, Balow JE (2003) New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney. Curr Opin Nephrol Hypertens 12:267–272

    CAS  Article  Google Scholar 

  19. 19.

    Booth AD, Pusey CD, Jayne DR (2004) Renal vasculitis—an update in 2004. Nephrol Dial Transplant 19:1964–1968

    Article  Google Scholar 

  20. 20.

    Hattori M, Kurayama H, Koitabashi Y, Japanese Society for Pediatric Nephrology (2001) Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 12:1493–1500

    CAS  PubMed  Google Scholar 

  21. 21.

    Noth I, Strek ME, Leff AR (2003) Churg–Strauss syndrome. Lancet 361:587–594

    Article  Google Scholar 

  22. 22.

    Grau RG (2008) Churg-Strauss syndrome: 2005–2008 update. Curr Rheumatol Rep 10:453–458

    CAS  Article  Google Scholar 

  23. 23.

    Beasley R, Bibby S, Weatherall M (2008) Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander? Thorax 63:847–849

    Article  Google Scholar 

  24. 24.

    Zwerina J, Eger G, Englbrecht M, Manger B, Schett G (2009) Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. Semin Arthritis Rheum doi:https://doi.org/10.1016/j.semarthrit.2008.05.004

  25. 25.

    Wiik A (2008) Drug-induced vasculitis. Curr Opin Rheumatol 20:35–39

    Article  Google Scholar 

  26. 26.

    Gao Y, Zhao MH (2009) Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 14:33–41

    CAS  Article  Google Scholar 

  27. 27.

    Laux-End R, Inaebnit D, Gerber HA, Bianchetti MG (1996) Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 75:355–356

    CAS  Article  Google Scholar 

  28. 28.

    Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL (2003) Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 63:1079–1085

    Article  Google Scholar 

  29. 29.

    Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007) Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 298:655–669

    CAS  Article  Google Scholar 

  30. 30.

    Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310–317

    CAS  Article  Google Scholar 

  31. 31.

    Lee RW, D'Cruz DP (2008) Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Drugs 68:747–770

    CAS  Article  Google Scholar 

  32. 32.

    Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD, European Vasculitis Study Group (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180–2188

    Article  Google Scholar 

  33. 33.

    Walsh M, Jayne D (2009) Targeting the B cell in vasculitis. Pediatr Nephrol 24:1267–1275

    Article  Google Scholar 

  34. 34.

    Simonetti GD, Santoro L, Ferrarini A, Crosazzo-Franscini L, Fossali E, Bianchetti MG, CHILD Project (2007) Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management. Paediatr Drugs 9:413–418

    Article  Google Scholar 

  35. 35.

    Hadtstein C, Schaefer F (2008) Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 23:363–371

    Article  Google Scholar 

  36. 36.

    Quan A (2006) Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82:23–28

    CAS  Article  Google Scholar 

Download references

Conflict of interest

There are no conflicts of interest.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mario G. Bianchetti.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Vanoni, F., Bettinelli, A., Keller, F. et al. Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood. Pediatr Nephrol 25, 205–212 (2010). https://doi.org/10.1007/s00467-009-1253-3

Download citation

Keywords

  • Churg-Strauss angiitis
  • Drug-induced vasculitis
  • Microscopic polyangiitis
  • Renal-limited vasculitis
  • Review
  • Wegener granulomatosis